Literature DB >> 29884856

Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma.

Ivana Moor1, Vera U Bacher2, Barbara Jeker1, Behrouz Mansouri Taleghani2, Beatrice U Mueller3, Peter Keller4, Daniel Betticher5, Thomas Egger6, Urban Novak1, Thomas Pabst1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29884856     DOI: 10.1038/s41409-018-0245-y

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy.

Authors:  Luzalba Sanoja-Flores; Juan Flores-Montero; Noemi Puig; Teresa Contreras-Sanfeliciano; Roberia Pontes; Alba Corral-Mateos; Omar García-Sánchez; María Díez-Campelo; Roberto José Pessoa de Magalhães; Luis García-Martín; José María Alonso-Alonso; Aranzazú García-Mateo; Carlos Aguilar-Franco; Jorge Labrador; Abelardo Barez-García; Angelo Maiolino; Bruno Paiva; Jesús San Miguel; Elaine Sobral da Costa; Marcos González; María Victoria Mateos; Brian Durie; Jacques J M van Dongen; Alberto Orfao
Journal:  Blood       Date:  2019-12-12       Impact factor: 22.113

2.  Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity with Novel Induction Regimens in Multiple Myeloma.

Authors:  Susan Bal; Heather J Landau; Gunjan L Shah; Michael Scordo; Parastoo Dahi; Oscar B Lahoud; Hani Hassoun; Malin Hultcrantz; Neha Korde; Nikoletta Lendvai; Alexander M Lesokhin; Sham Mailankody; Urvi A Shah; Eric Smith; Sean M Devlin; Scott Avecilla; Ahmet Dogan; Mikhail Roshal; Ola Landgren; Sergio A Giralt; David J Chung
Journal:  Biol Blood Marrow Transplant       Date:  2020-05-19       Impact factor: 5.742

3.  Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial.

Authors:  Sarah Farag; Ulrike Bacher; Barbara Jeker; Myriam Legros; Gaelle Rhyner; Jean-Marc Lüthi; Julian Schardt; Thilo Zander; Michael Daskalakis; Behrouz Mansouri; Chantal Manz; Thomas Pabst
Journal:  Bone Marrow Transplant       Date:  2022-04-20       Impact factor: 5.174

Review 4.  Is Quantification of Measurable Clonal Plasma Cells in Stem Cell Grafts (gMRD) Clinically Meaningful?

Authors:  Guldane Cengiz Seval; Meral Beksac
Journal:  Front Oncol       Date:  2022-02-23       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.